Ozempic Shows Promise Beyond Diabetes Treatment

New studies suggest potential benefits for dementia, addiction, and cardiovascular health.

University of Oxford analysis reveals Ozempic may reduce dementia risk by up to 48% in diabetes patients.
Semaglutide, the active ingredient, found to lower nicotine dependence and potentially other addictive behaviors.
Research indicates anti-inflammatory properties could protect against cognitive decline and neurodegenerative diseases.
Early trials suggest benefits for heart attack, stroke prevention, and even certain cancers.
Further controlled trials are necessary to confirm these observational findings.